Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Mudan Granule (Combined With Methylcobalamin) on Type 2 Diabetic Peripheral Neuropathy: A Randomized,Double-blind,Placebo-controlled, Parallel-arm,Multi-center Trial

NCT04711980 is registered in ClinicalTrials.gov with Fengmei Lian as lead sponsor.

NCT NCT04711980
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04711980 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Mudan Granule (Combined With Methylcobalamin) on Type 2 Diabetic Peripheral Neuropathy: A Randomized,Double-blind,Placebo-controlled, Parallel-arm,Multi-center Trial
Lead sponsor
Fengmei Lian
Phase
Phase 1
Overall status
Unknown status
Start date
June 30, 2021
Completion date
September 30, 2022
Enrollment
402 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic peripheral neuropathy type 2